Search results
Showing 21 to 30 of 66 search results for Statement on DP15/4 - General insurance value measures.
-
Unfair contract terms library
The FCA's work on unfair contract terms including past undertakings, agreements and other publications. -
FCA outcomes and metrics
The FCA is committed to being clear about how it is accountable for its progress. On this page the FCA sets out its outcomes and the metrics it will use to measure them. -
General insurance value measures data 2022
The FCA has published value measures data for a wide range of General Insurance (GI) Products for January to December 2022. -
CP15/41: Increasing transparency and engagement at renewal in general insurance markets
CP15/41: Increasing transparency and engagement at renewal in general insurance markets (PDF). ... The measures we are consulting on apply to insurers and intermediaries selling retail general insurance products. -
2013 Disclosure Log
The aim of the FCA's Disclosure Log is to keep information that it has released under the Freedom of Information Act and which it thinks is of wider public interest. Find the Disclosure Log for 2013. -
PS15/13: Guaranteed Asset Protection insurance: competition remedy
In this Policy Statement we report on the main issues arising from Consultation Paper 14/29 Guaranteed Asset Protection insurance: a competition remedy and publish the final rules. -
How we calculate annual fees
Find out what the FCA considers when calculating your annual fee, and read about fee blocks, extra fees and thresholds. -
FCA confirms guidance for insurance firms on assessing product value
The Financial Conduct Authority (FCA) is today confirming guidance for insurance firms to consider the impact of coronavirus (Covid-19) on the value of their insurance products -
Improving access to insurance
Speech by Christopher Woolard, Executive Director of Strategy and Competition at the FCA, delivered at the FCA Insurance Access event. -
Product value and coronavirus: draft guidance for insurance firms
FCA guidance on our expectations for insurance firms to consider the value of their products in the coronavirus situation.